amitriptyline has been researched along with Burning Mouth Syndrome in 6 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Burning Mouth Syndrome: A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This retrospective study aimed to evaluate the efficacy of clonazepam and amitriptyline in the treatment of burning mouth syndrome (BMS)." | 7.85 | Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study. ( Arrive, E; Catros, S; Fenelon, M; Fricain, JC; Quinque, E, 2017) |
| "To assess the efficacy of anti-xerostomic topical medication (urea 10%) in patients with burning mouth syndrome (BMS)." | 5.19 | The role of xerostomia in burning mouth syndrome: a case-control study. ( Silva, LA; Siqueira, JT; Siqueira, SR; Teixeira, MJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Paudel, D | 1 |
| Utsunomiya, M | 1 |
| Yoshida, K | 1 |
| Giri, S | 1 |
| Uehara, O | 1 |
| Matsuoka, H | 1 |
| Chiba, I | 1 |
| Toyofuku, A | 3 |
| Abiko, Y | 1 |
| Fenelon, M | 1 |
| Quinque, E | 1 |
| Arrive, E | 1 |
| Catros, S | 1 |
| Fricain, JC | 1 |
| Kawasaki, K | 1 |
| Nagamine, T | 1 |
| Watanabe, T | 1 |
| Suga, T | 1 |
| Tu, TTH | 1 |
| Sugawara, S | 1 |
| Mikuzuki, L | 1 |
| Miura, A | 1 |
| Shinohara, Y | 1 |
| Yoshikawa, T | 1 |
| Takenoshita, M | 2 |
| Silva, LA | 1 |
| Siqueira, JT | 1 |
| Teixeira, MJ | 1 |
| Siqueira, SR | 1 |
| Motomura, H | 1 |
| Gorsky, M | 1 |
| Silverman, S | 1 |
| Chinn, H | 1 |
1 trial available for amitriptyline and Burning Mouth Syndrome
| Article | Year |
|---|---|
The role of xerostomia in burning mouth syndrome: a case-control study.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analgesics, Non-Narcotic; Burning Mouth Syndrome; Cas | 2014 |
5 other studies available for amitriptyline and Burning Mouth Syndrome
| Article | Year |
|---|---|
Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
Topics: Adult; Aged; Amitriptyline; Benzodiazepines; Burning Mouth Syndrome; Drug Therapy, Combination; Fema | 2020 |
Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
Topics: Aged; Amitriptyline; Analgesics, Non-Narcotic; Burning Mouth Syndrome; Clonazepam; Female; GABA Modu | 2017 |
An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome.
Topics: Adult; Aged; Amitriptyline; Analgesics, Non-Narcotic; Burning Mouth Syndrome; Female; Humans; Male; | 2018 |
Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases.
Topics: Aged; Amitriptyline; Analgesics, Non-Narcotic; Antipsychotic Agents; Aripiprazole; Burning Mouth Syn | 2017 |
Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antifungal Agents; Burning Mouth Syndrome; Chlordiaze | 1991 |